Describe Intravenous Induction Agents — Overview in detail.

Definition & Role

Intravenous (IV) anaesthetic agents are drugs injected into a vein to produce a rapid loss of consciousness. They are used chiefly for the induction of anaesthesia (a smooth, quick transition through the excitement stage) and, by infusion, for maintenance (total intravenous anaesthesia) and sedation. Their speed of onset reflects rapid delivery to the well-perfused, lipid-rich brain.

Onset & Offset — Redistribution

After a single induction dose, consciousness is lost within one arm–brain circulation time (~30 s), as the drug reaches the brain. Recovery from that single dose is due mainly to redistribution of the drug from the brain to other tissues (muscle, then fat), not to its metabolism — so awakening is rapid even for drugs (like thiopentone) that are slowly metabolised. Repeated doses or infusions saturate the tissues and prolong recovery.

The Ideal IV Agent

An ideal IV agent would be: water-soluble and stable; rapid, smooth onset in one circulation time; rapid recovery without hangover; cardiovascularly and respiratorily stable; non-irritant (no pain on injection, safe if extravasated); without histamine release or hypersensitivity; analgesic; anti-emetic; and cheap. As with inhalational agents, none is ideal, so the choice is individualised.

Mechanism (brief)

Most IV agents (propofol, thiopentone, etomidate, benzodiazepines) act by potentiating the inhibitory neurotransmitter GABA at the GABA_A receptor, enhancing chloride influx and neuronal inhibition. Ketamine is the exception — it acts mainly by antagonising the excitatory NMDA receptor, producing ‘dissociative’ anaesthesia.

Combining Drugs — the Balanced Technique

In modern practice the intravenous induction agent is almost never used alone but as one element of a balanced technique: the hypnotic (propofol, thiopentone, etomidate or ketamine) provides unconsciousness, an opioid provides analgesia and blunts the pressor response to laryngoscopy, and a muscle relaxant is added when intubation or surgical relaxation is required. Because these drugs interact — often synergistically — the dose of each is reduced when they are combined, which improves cardiovascular stability and smoothness of induction but also means that respiratory depression and hypotension can be additive, so the drugs are titrated to effect rather than given in fixed doses.

Speed of Onset & the Effect-site

The rapidity of an intravenous induction depends on how quickly the drug reaches its site of action in the brain, which is why the induction dose is delivered as a bolus into a flowing intravenous line and takes effect within an arm–brain circulation time. There is, however, a short delay between the peak blood concentration and the peak brain (effect-site) concentration — the drug must cross from plasma into the central nervous system — so the experienced anaesthetist injects and then waits for this equilibration before judging the effect, avoiding the error of giving a second dose too soon. A slow circulation time, as in the shocked or low-cardiac-output patient, prolongs the arm–brain time and a given dose reaches a higher peak concentration, so induction agents are given more slowly and in reduced dose in such patients.

Redistribution, not metabolism, terminates the effect of a single dose.

• IV agents: rapid loss of consciousness for induction; also infusion (TIVA) & sedation.
• Onset in one arm–brain circulation time; recovery from a single dose is by redistribution, not metabolism.
• Ideal agent: rapid smooth on/off, cardiostable, non-irritant, analgesic, anti-emetic, cheap — none is ideal.
• Most act via GABA_A potentiation; ketamine is an NMDA antagonist (dissociative).
• Repeated doses/infusions saturate tissues and prolong recovery.